Anti-E Would Be Difficult to Rule Out When Using a Double-Dose Cell in the Presence of Anti-c
In the presence of anti-c, anti-E would be difficult to rule out if the laboratory policy required the use of a double-dose cell (option A).
Explanation of Antibody Exclusion in Transfusion Medicine
When identifying antibodies in transfusion medicine, proper exclusion of additional antibodies is critical to prevent hemolytic transfusion reactions. The challenge with using double-dose cells in antibody identification is that certain antibody combinations can mask each other.
Why Anti-E is Difficult to Rule Out
Cell Selection Principles:
- Testing with r'r and r"r reagent cells is the most effective method for excluding additional antibodies 1
- r'r cells are homozygous for c and E antigens
- r"r cells are homozygous for C and e antigens
The Problem with Double-Dose Cells:
- When anti-c is present, it will react with cells that have the c antigen
- If using a double-dose cell that has both c and E antigens (r'r), the anti-c reactivity would mask any potential anti-E reactivity
- This makes it impossible to determine if anti-E is also present alongside anti-c
Clinical Significance:
Antibody Identification Best Practices
The American Society of Hematology (ASH) recommends:
- Using cells that lack the antigen against which a previously documented antibody is directed 1
- Including at least one RBC sample from a donor who is homozygous for clinically significant antigens 1
- Selecting antigen-negative units based on the patient's complete antibody profile 1
Prevalence and Clinical Impact
- Anti-E is the most frequently identified Rh antibody in some populations (61.70% of Rh antibodies in one study) 4
- Both anti-c and anti-E can cause acute and delayed hemolytic transfusion reactions 3
- Multiple alloantibodies significantly complicate finding compatible blood units for future transfusions 1
Practical Approach to Antibody Identification
To properly identify anti-E in the presence of anti-c:
- Use cells that are c-negative to eliminate the anti-c reactivity
- Test these c-negative cells for E antigen reactivity
- Confirm with additional testing methods if necessary
Pitfalls to Avoid
- Never rely solely on double-dose cells when a patient has a known antibody that would react with those cells
- Don't assume a single antibody when multiple antibodies may be present
- Avoid delaying extended phenotyping or genotyping for patients with antibodies, as this can prevent future transfusion complications 1
The ASH guidelines strongly recommend prophylactic red cell antigen matching for Rh antigens (including E) and K antigens to prevent alloimmunization, particularly in high-risk patients 5, 1.